Price
73.62
+1.99%52W Range
Market Cap
₹262.75 Cr
Traded: ₹0.06 Cr (0.02%) 0.0x
Free Float: ₹98.48 Cr (0.06% of FF traded)
Volume · 60D trend
7.62 K 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | +0.0% | +8.0% | +11.0% | -- | -3.0% | Stable |
| ROE | -- | -- | -2.0% | -- | -- | -- |
| Return | +0.0% | -5.0% | -16.0% | -35.0% | -- | Decelerating |
| Profit | -- | +1.0% | -32.0% | -- | -219.0% | Decelerating |
Quarterly Results
Mar 2023
Dec 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 42 | 28 | 31 | 37 | 33 | 33 | 34 | 41 | 30 | 28 | 33 | 28 | 23 | 22 | 18 |
| Expenses | 38 | 34 | 29 | 39 | 29 | 29 | 29 | 36 | 26 | 26 | 26 | 24 | 20 | 19 | 16 |
| Operating Profit | 5 | -6 | 2 | -3 | 4 | 4 | 5 | 5 | 4 | 2 | 7 | 4 | 3 | 3 | 2 |
| OPM % | 10.8% | -23.0% | 5.4% | -6.9% | 11.1% | 12.2% | 15.4% | 12.0% | 12.3% | 7.3% | 21.1% | 14.9% | 11.5% | 14.8% | 12.4% |
| Other Income | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | -0 | 0 | 0 | -6 |
| Interest | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 3 | 3 | 4 | 3 | 3 | 3 |
| Profit Before Tax | 2 | -9 | -0 | -4 | 1 | 3 | 4 | 3 | 2 | -2 | 3 | -1 | -2 | -3 | -10 |
| Tax % | -5.1% | -6.1% | -6.3% | -26.6% | 26.7% | 32.9% | 24.3% | 28.4% | 30.6% | 28.2% | 38.6% | -22.8% | 7.2% | 0.0% | 2.2% |
| Net Profit | 2 | -8 | -0 | -3 | 1 | 2 | 3 | 2 | 1 | -2 | 2 | -0 | -2 | -3 | -10 |
| Exceptional Items | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | -0 | -7 |
| EPS (Rs) | 0.6 | -2.1 | 0.0 | -0.9 | 0.3 | 0.5 | 0.8 | 0.6 | 0.4 | -0.6 | 0.5 | -0.1 | -0.6 | -1.0 | -3.6 |
| Sales Growth (YoY) | 28.1% | -16.1% | -9.1% | -10.9% | 9.7% | 20.4% | 3.8% | 47.0% | 31.6% | 24.9% | 82.7% | -- | -- | -- | -- |
| Sales Growth (QoQ) | 51.0% | -8.8% | -16.2% | 11.0% | -1.2% | -1.1% | -17.9% | 36.7% | 8.4% | -14.7% | 16.3% | 22.3% | 2.9% | 24.8% | -- |
| OP Growth (YoY) | 23.6% | -258.1% | -68.2% | -151.3% | -0.8% | 102.0% | -24.5% | 18.7% | 40.5% | -38.8% | 210.9% | -- | -- | -- | -- |
| OP Growth (QoQ) | 170.5% | -490.9% | 165.0% | -169.0% | -9.8% | -21.4% | 4.8% | 33.4% | 83.7% | -70.6% | 64.7% | 58.0% | -20.0% | 49.3% | -- |
| Profit Growth (YoY) | 123.0% | -530.0% | -100.0% | -260.0% | -35.0% | 184.0% | 52.0% | 1500.0% | 178.0% | 20.0% | 147.0% | 12.0% | -574.0% | 89.0% | -162.0% |
| EPS Growth (YoY) | 119.2% | -526.0% | -100.0% | -259.3% | -35.0% | 179.4% | 40.7% | 493.3% | 171.4% | 35.7% | 114.9% | -- | -- | -- | -- |
| EPS Growth (QoQ) | 126.8% | -- | 100.0% | -461.5% | -48.0% | -34.2% | 28.8% | 47.5% | 163.5% | -216.7% | 460.0% | 73.2% | 42.9% | 73.0% | -- |
| OP Margin | 10.8% | -23.0% | 5.4% | -6.9% | 11.1% | 12.2% | 15.4% | 12.0% | 12.3% | 7.3% | 21.1% | 14.9% | 11.5% | 14.8% | 12.4% |
| Net Margin | 4.8% | -28.8% | -0.5% | -8.8% | 3.0% | 6.1% | 8.0% | 4.6% | 4.3% | -7.5% | 5.5% | -1.8% | -8.1% | -13.5% | -58.5% |
| Material Cost % | 38.9% | 39.4% | 37.6% | 40.6% | 38.6% | 39.2% | 38.6% | 43.6% | 38.2% | 43.1% | 35.8% | 41.8% | 41.6% | 35.7% | 33.6% |
| Employee Cost % | 27.2% | 46.1% | 30.9% | 28.4% | 27.4% | 28.8% | 25.1% | 20.3% | 27.2% | 26.0% | 22.0% | 23.0% | 26.0% | 23.5% | 25.8% |
| P/S | 1.91 | 1.78 | 1.65 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 2.83 | 2.56 | 2.18 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50As per the letter attached
As per the letter attached
As per the letter attached
As per the letter attached
As per the letter attached
As per the letter atatched
As per the letter attached
Lyka Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 ,inter alia, to consider and approve As per the letter attached
As per the letter attached
As per the letter attached
As per the letter attached
As per the letter attached
As per the letter attached
As per the letter attached
As per the letter attached
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kunal Gandhi & PACs
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kunal Gandhi & Others
As per letter attached
As per letter attached
As per the letter attached
As per the letter attached
Clarification on Price Movement
The Exchange has sought clarification from Lyka Labs Ltd on June 11, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant information ....
As per regulation 47 of the SEBI (LODR) Regulations, 2015 the extract of Audited Financial Results (Standalone and Consolidated) for the quarter and year ended 31.03.2026 were published ....
Annual Secretarial Compliance Report for the year ended 31.03.2026
As per the letter attached
As per the letter attached
Lyka Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2026 ,inter alia, to consider and approve As per letter attached
Pursuant to Regulation 30 of the SEBI (LODR) Regulations 2015 we wish to inform you that India Rating & Research Pvt. Ltd. has assigned/affirmed the rating of the bank facilities availed ....
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
As per the letter attached
As per the letter attached
The Exchange has sought clarification from Lyka Labs Ltd on April 8, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant information ....
As per the letter attached
As per the letter attached
Closure of Trading Window
Lyka Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/03/2026 ,inter alia, to consider and approve As per the letter attached
Update on the Scheme of Merger- Approved by NCLT Bench
As per letter attached
As per the letter attached
As per the letter attached
As per the letter attached
As per letter attached
As per the letter attached
Lyka Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2026 ,inter alia, to consider and approve As per the letter atatched
As per letter attached
As per the letter attached
As per the letter attached
As per letter atatched
As per the letter attached
Annual Reports
15